Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range
May 16, 2014 ryan arthur f Director Disposition (Non Open Market) 2,355 n/a
Apr 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 700 n/a
Mar 28, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 300.28 - 315.33
Mar 27, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 302.96 - 316.49
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Mar 24, 2014 baker charles a Director Option Execute 15,000 23.84
Mar 24, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 299.01 - 314.22
Mar 21, 2014 sanofi Beneficial Owner (10% or more) Buy 305,115 313.12 - 332.78
Mar 20, 2014 sanofi Beneficial Owner (10% or more) Buy 57,957 325.94 - 328.93
Mar 19, 2014 sanofi Beneficial Owner (10% or more) Buy 9,746 326.44 - 328.67
Mar 17, 2014 brown michael s Director Automatic Sell 2,000 333.42 - 336.49
Mar 17, 2014 brown michael s Director Option Execute 2,000 33.42
Mar 17, 2014 sanofi Beneficial Owner (10% or more) Buy 60,128 328.32 - 328.86
Mar 14, 2014 sanofi Beneficial Owner (10% or more) Buy 55,583 326.77 - 329.00
Mar 12, 2014 sanofi Beneficial Owner (10% or more) Buy 220,995 325.40 - 339.27
Mar 11, 2014 sanofi Beneficial Owner (10% or more) Buy 180,710 328.82 - 335.68
Mar 10, 2014 sanofi Beneficial Owner (10% or more) Buy 199,822 325.34 - 332.26
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 69,873 304.21 - 325.82
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 241,818 327.77 - 339.06
Showing 161-180 of 938 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)